PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma.
Muz B, Buggio M, Azab F, de la Puente P, Fiala M, Padval MV, Weaver DT, Pachter JA, Vij R, Azab AK.
Muz B, et al.
Haematologica. 2019 Jul;104(7):e310-e313. doi: 10.3324/haematol.2018.194688. Epub 2019 Jan 17.
Haematologica. 2019.
PMID: 30655367
Free PMC article.
No abstract available.